|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
      |
|||||||||||||
 |
 |
|||||||||||||
   
 |
||||||||||||||
Patents & Licenses
MiMedx holds an exclusive, worldwide license with Shriners Hospitals for Children and the University of South Florida Research Foundation for NDGA technology. It covers the polymerization chemistry of NDGA as applied to any biological material, bioprosthesis or device created through its application.
Under this license, MiMedx owns rights to the following patents:
- US 6,565,960 (Koob et al)
- US 6,821,530 (Koob et al)
These statements have not been reviewed by the FDA.
This website is not meant as a substitute for professional medical advice.
|
|
 |
|
